Category: Colorectal Cancer: News, Information & Studies

Colorectal Cancer

Colorectal cancer is a significant health concern affecting both men and women worldwide. As one of the most common cancers, understanding the basics of this disease is crucial for early detection and successful treatment outcomes.

Worldwide, colorectal cancer is the third most common cancer and the fourth most common cause of cancer-related deaths. According to the World Health Organization, in 2020, there were 1.9 million new cases and 935,000 deaths from colorectal cancer globally.(Continued ../)

Dendritic Cell Therapy Bladder Cancer Statistics

Success rates of Dendritic Cell Therapy on Bladder Cancer Patients at Immucura

Bladder cancer is a type of cancer that starts in the cells of the bladder, the organ in the pelvis that stores urine. In the face of this challenge, medical
Esophageal cancer

The Impact of Dendritic Cell Therapy on Esophageal Cancer at Immucura

According to recent data from Immucura, the incidence of esophageal cancer remains considerable, with a substantial number of new cases diagnosed each year. In the face of this challenging reality,
The Efficacy of Dendritic Cell Therapy on Colorectal Cancer at Immucura

The Efficacy of Dendritic Cell Therapy on Colorectal Cancer at Immucura

Colorectal Cancer, often referred to as colon cancer, is a type of cancer that starts in the colon or rectum, which are parts of the digestive system. It typically begins
Lifestyle and Diet: A Colorectal Cancer Connection

Lifestyle and Diet: A Colorectal Cancer Connection

This article explores the critical relationship between lifestyle choices and diet in relation to the risk of developing colorectal cancer, a prevalent and potentially life-threatening disease affecting the colon and
Revolutionizing Colorectal Cancer Therapy: Cutting-Edge Approaches and Breakthroughs

Revolutionizing Colorectal Cancer Therapy: Cutting-Edge Approaches and Breakthroughs

Colorectal cancer presents a significant global health concern, but recent years have seen remarkable progress in therapy. Advancements include precision and minimally invasive surgical techniques, personalized chemotherapy through molecular profiling,

STUDY: Dendritic Cell Vaccine Therapy for Colorectal Cancer

In the pursuit of disrupting tumor growth, a groundbreaking approach emerges through dendritic cell (DC) vaccines that target tumor-derived blood vessels, unleashing potent immune responses to combat cancer.

Colorectal Cancer: the third most common cancer worldwide

Colorectal cancer is a type of cancer that affects the colon or rectum, which are parts of the large intestine. It usually starts as a polyp, which is a small growth on the inner lining of the colon or rectum, and can develop into cancer over time.

Worldwide, colorectal cancer is the third most common cancer and the fourth most common cause of cancer-related deaths. According to the World Health Organization, in 2020, there were 1.9 million new cases and 935,000 deaths from colorectal cancer globally.

Colorectal cancer is a significant public health concern worldwide, with varying incidence rates across different regions. In 2020, the World Health Organization reported that Europe had the highest incidence rate of colorectal cancer at 11.8%, followed by Asia at 10.6%, Latin America at 9.2%, Northern America at 7.1%, and Oceania at 8.1%. However, Africa had the lowest incidence rate at 6%. These regional differences in incidence rates may be due to factors such as differences in diet, lifestyle, genetics, and screening practices.

Europeans tend to have a diet that is high in processed meats, which has been linked to an increased risk of colorectal cancer. Additionally, sedentary lifestyles and obesity are more prevalent in Europe, both of which are risk factors for developing the disease. It is important for individuals to be aware of their risk factors and to take preventative measures, such as adopting a healthy diet and exercising regularly, to reduce their risk of developing colorectal cancer.

The treatment for colorectal cancer depends on the stage of the cancer, which is determined by how far it has spread. The main treatments for colorectal cancer include surgery, chemotherapy, and radiation therapy. In early stages of the cancer, surgery alone may be sufficient, while in later stages, a combination of treatments may be required.

How can Colorectal Cancer be diagnosed?

Colorectal cancer can be diagnosed through various methods, including:

  1. Screening tests: These tests are used to detect colon or rectal cancer in people who do not have any symptoms. Common screening tests include: colonoscopy, flexible sigmoidoscopy, fecal occult blood test, and stool DNA test.

  2. Biopsy: If a suspicious area is found during a screening test or physical exam, a biopsy may be done to remove a small sample of tissue for analysis. A pathologist will examine the tissue under a microscope to look for cancer cells.

  3. Imaging tests: These tests can help determine the stage and location of the cancer. Common imaging tests include computed tomography (CT) scan, magnetic resonance imaging (MRI), and positron emission tomography (PET) scan.

  4. Blood tests: Certain blood tests, such as carcinoembryonic antigen (CEA) test, can help monitor the progress of colorectal cancer and detect any recurrence.

It is important to note that a diagnosis of colorectal cancer can only be confirmed through a biopsy. If you experience symptoms such as persistent abdominal pain, changes in bowel habits, rectal bleeding, or unexplained weight loss, you should talk to your doctor about getting screened for colorectal cancer.

Immucura’s Diagnostics Program aims to provide an early diagnosis of colorectal cancer, a disease that is highly treatable if caught early. The program includes innovative diagnostic tools and tests that can detect colorectal cancer in its early stages, allowing for timely intervention and improved outcomes. Early detection is crucial for successful treatment and can significantly increase the chances of survival. Immucura’s Diagnostics Program plays a vital role in improving patient outcomes and reducing the impact of colorectal cancer on individuals and society.

Here you can check more information about this program Immucura Diagnostics

The Stages of Colorectal Cancer

Stage 0: The cancer is only in the innermost lining of the colon or rectum.

Stage I: The cancer has grown into the deeper layers of the colon or rectum, but has not spread beyond the wall of the colon or rectum.

Stage II: The cancer has grown through the wall of the colon or rectum and may have invaded nearby tissues or organs, but has not spread to the lymph nodes.

Stage III: The cancer has spread to nearby lymph nodes, but has not spread to other parts of the body.

Stage IV: The cancer has spread to other parts of the body, such as the liver, lungs, or other organs.

The recovery chances for colorectal cancer depend on the stage at diagnosis, as well as other factors such as the patient’s age, overall health, and response to treatment. In general, the earlier the cancer is diagnosed and treated, the better the chances of recovery.

Dendritic Cell Therapy for Colorectal Cancer

Dendritic Cell Therapy is an Immunotherapy that involves using a patient’s own immune cells, called dendritic cells, to stimulate the immune system to attack cancer cells. There is evidence that Dendritic Cell Therapy may be effective in treating some types of cancer, including colorectal cancer.

One important thing about the Dendritic Cell Therapy is that it can be combined with any other cancer therapy, such as chemotherapy or radiation, to enhance their effectiveness. It is a natural treatment option that doesn’t have any harsh side effects. Moreover, it can be used to treat various types of cancer like colorectal cancer.

Immucura offers personalized treatment plans tailored to the specific needs of each patient. Immucura’s experienced team work to provide comprehensive care and support to our patients. Immucura believes in the power of Dendritic Cell Therapy as a promising alternative to traditional cancer treatments.

Immucura’s patients’ stories corroborate the success of Dendritic Cell Therapy, such as Esad’s case: “I discovered Immucura for my father as i was searching for other options and since we started with them, we have been very satisfied. The care and availability of their team is really great. We can only recommend Immucura.”Here you can find more testimonials: Success stories.

Get In Touch